IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Pear Therapeutics Inc

Q4 2023 vs Q1 2024

Comparing institutional holders between quarters

Quarters

Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile
Roble, Belko & Company, Inc
UNCHANGED
Shares4,502 from 4,502
Change0 (0%)
Value$0 ($0)
Filed 2024-04-11
Status
Roble, Belko & Company, Inc
UNCHANGED4,5024,50200%$0$0$02024-04-11
Showing 1 of 1 institutions